291 related articles for article (PubMed ID: 18029831)
1. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
2. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
[TBL] [Abstract][Full Text] [Related]
5. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
[TBL] [Abstract][Full Text] [Related]
7. Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy?
Mitchell CR; Umbreit EC; Rangel LJ; Bergstralh EJ; Karnes RJ
Urology; 2011 Oct; 78(4):868-72. PubMed ID: 21843902
[TBL] [Abstract][Full Text] [Related]
8. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
[TBL] [Abstract][Full Text] [Related]
9. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
[TBL] [Abstract][Full Text] [Related]
10. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
11. The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance.
Choi HC; Park JH; Cho BL; Son KY; Yoo YJ; Kwon HT
BJU Int; 2011 Dec; 108(11):1756-61. PubMed ID: 21507191
[TBL] [Abstract][Full Text] [Related]
12. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
13. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
Zhao S; Xia M; Tang J; Yan Y
BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
[TBL] [Abstract][Full Text] [Related]
14. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
Freedland SJ; Platz EA; Presti JC; Aronson WJ; Amling CL; Kane CJ; Terris MK
J Urol; 2006 Feb; 175(2):500-4; discussion 504. PubMed ID: 16406980
[TBL] [Abstract][Full Text] [Related]
15. Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.
Goris Gbenou MC; Peltier A; Schulman CC; Velthoven Rv
Urol Oncol; 2016 Jun; 34(6):254.e1-6. PubMed ID: 26822075
[TBL] [Abstract][Full Text] [Related]
16. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
Freedland SJ; Bañez LL; Sun LL; Fitzsimons NJ; Moul JW
Prostate Cancer Prostatic Dis; 2009; 12(3):259-63. PubMed ID: 19581922
[TBL] [Abstract][Full Text] [Related]
17. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
18. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
19. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
